SCHEMBL9054953

SCHEMBL9054953

O=C1NC([N+](=O)[O-])C(=O)Nc2cc(Cl)c(Cl)c([N+](=O)[O-])c21

nearest known ligand 0.44

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
GRIN2D O15399 6/20 0.40
GRIN3B O60391 6/20 0.40
GRIN1 Q05586 6/20 0.40
GRIN2A Q12879 6/20 0.40
GRIN2B Q13224 6/20 0.40
GRIN2C Q14957 6/20 0.40
GRIN3A Q8TCU5 6/20 0.40
ALDH1A1 P00352 2/20 0.37
PKM P14618 1/20 0.31
CES1 P23141 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8871838 0.87 CES1 (0.33) TSHRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8872392 0.85 TSHR (0.45) TSHRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL9055573 0.80 CES1 (0.47) TSHRALDH1A1CES1
SCHEMBL9054278 0.80 GRIN2D (0.32) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8873725 0.80 GRIN2D (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL8873611 0.78 DCTPP1 (0.40) TSHRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8872554 0.77 TSHR (0.33) TSHRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3741100 0.77 TSHR (0.52) TSHRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8874096 0.76 TSHR (0.50) TSHRGRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL8873603 0.74 TSHR (0.45) TSHRGRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996004288-A1 GLYCINE RECEPTOR ANTAGONIST PHARMACOPHORE STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) 1996-02-15 WO disclosed